Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

China · Delayed Price · Currency is CNY

10.22

-1.08 (-9.56%)

Nov 13, 2026, 3:04 PM CST

SHE:300534 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	710.26	886.96	1,043	1,080	799.68	287.81
Revenue Growth	-21.34%	-14.92%	-3.48%	35.06%	177.85%	12.91%
Gross Profit	464.69	603.55	751.13	693.26	458.06	92.33
Operating Income	53.89	87.47	96.02	81.82	56.31	-9.31
Net Income	24.57	43.95	24.48	61.65	38.79	-9.11
Earnings Per Share	0.08	0.14	0.08	0.20	0.13	-0.03
EPS Growth	12.46%	79.55%	-60.28%	58.87%	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
China	874.83	1,034	1,071	789.4	275.55
Foreign	12.13	8.4	8.63	10.28	12.26
Total	886.96	1,043	1,080	799.68	287.81

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	210.76	241.33	310.02	288.95	369.24	99.12
Total Debt	139.25	132.51	114.68	144.54	-	-
Net Cash (Debt)	71.51	108.82	195.34	144.4	369.24	99.12
Net Cash Growth	50.09%	-44.29%	35.27%	-60.89%	272.52%	105.97%
Net Cash Per Share	0.24	0.36	0.64	0.48	1.22	0.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	92.46	-6.54	214.92	96.53	267.44	51.13
Capital Expenditures	-27.66	-43.36	-77.69	-126.36	-25.41	-0.41
Free Cash Flow	64.81	-49.9	137.23	-29.83	242.03	50.72
Free Cash Flow Growth	-	-	-	-	377.18%	103.30%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	65.43%	68.05%	72.05%	64.19%	57.28%	32.08%
Operating Margin	7.59%	9.86%	9.21%	7.58%	7.04%	-3.24%
Pretax Margin	9.44%	9.15%	9.76%	8.98%	8.27%	-1.65%
Profit Margin	3.46%	4.96%	2.35%	5.71%	4.85%	-3.16%
FCF Margin	9.12%	-5.63%	13.16%	-2.76%	30.27%	17.62%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.040	0.040	0.040	0.020
Dividend Per Share Growth	0%	0%	100.00%	-
Dividend Yield	0.39%	0.42%	0.46%	0.20%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	126.24	65.43	107.82	48.57	69.37	-
P/FCF Ratio	47.84	-	19.23	-	11.12	88.04
PS Ratio	4.36	3.24	2.53	2.77	3.37	15.51